CORRECTING and REPLACING Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8
July 20 2022 - 6:06PM
Business Wire
First paragraph, second sentence of release should read: Clovis’
senior management will host a conference call and live audio
webcast at 8:30am ET to discuss Clovis’ results and business
outlook in greater detail. (instead of Clovis’ senior management
will host a conference call and live audio webcast at 6:30am ET to
discuss Clovis’ results and business outlook in greater
detail.).
The updated release reads:
CLOVIS ONCOLOGY TO ANNOUNCE SECOND QUARTER
2022 FINANCIAL RESULTS AND HOST WEBCAST CONFERENCE CALL ON AUGUST
8
Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second
quarter 2022 financial results and provide an update on its
clinical development programs and regulatory and business outlook
on Monday, August 8, 2022, before the open of the US financial
markets. Clovis’ senior management will host a conference call and
live audio webcast at 8:30am ET to discuss Clovis’ results and
business outlook in greater detail.
The conference call will be simultaneously webcast on the Clovis
Oncology website www.clovisoncology.com, and a replay of the
webcast will be available for 30 days.
Dial-in numbers for the conference call are as follows: US
participants 888.440.4615 International participants 646.960.0682,
conference ID: 2259685.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing, and commercializing innovative anti-cancer
agents in the US, Europe, and additional international markets.
Clovis Oncology targets development programs at specific subsets of
cancer populations, and simultaneously develops with partners
diagnostic tools intended to direct a compound in development to
the population that is most likely to benefit from its use. Clovis
Oncology is headquartered in Boulder, Colorado; please visit
www.clovisoncology.com for more information, including additional
office locations in the US and Europe.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220720005107/en/
Clovis Investor Contacts: Anna Sussman 303.625.5022
asussman@clovisoncology.com
Breanna Burkart 303.625.5023 bburkart@clovisoncology.com
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Sep 2023 to Sep 2024